AP NEWS

Global & US Gene Therapy Market Forecast to 2020 - Gene Therapy for Hemophilia B Offers Significant Opportunity - ResearchAndMarkets.com

November 8, 2018

DUBLIN--(BUSINESS WIRE)--Nov 8, 2018--The “Global & US Gene Therapy Market Forecast to 2020” report has been added to ResearchAndMarkets.com’s offering.

Gene therapy is one of the most widely researched fields in the healthcare industry. The high potential of gene therapy to cure various chronic diseases makes it a popular research area. Various researches are being performed across the globe to explore the potential of gene therapy for the treatment of incurable diseases, such as diabetes, cancer, and HIV amongst others.The major part of the revenue of gene therapy market is generated from research phase. Most of the gene therapy products are in research phases, only few products have been commercialized till date. The report also provides the sales of major marketed gene therapy products, and the list of the products in clinical/pre-clinical research along with their clinical phases.North America continues to have the maximum number of clinical trials in the gene therapy segment. This is a major reason for the dominant position of North America in the gene therapy market.

Market Dynamics

Drivers

Failure of Conventional Therapies to Treat CancersRising Focus to Accelerate Commercialization of Gene Therapy in Developed NationsRising Incidence of Chronic and Life-Threatening DiseasesGrowing Interest of Venture Capital Firms

Restraints

Stringent Regulatory Laws & Safety ConcernsChallenges in Commercialization of Gene TherapyHigh Cost of the Gene Therapy DrugsPitfalls in Current TechniqueProduction & Manufacturing: A Unique Challenge for Gene Therapies

Opportunities

Approval of Gene Therapy Drug in EuropeGene Therapy for Hemophilia B Offers Significant Opportunity

Industry Trends

Gene Silencing: Gaining MomentumAdvanced Therapies: Combining Gene Therapy and Stem Cell TechnologyImmunodeficiency Syndromes: The Focus of Gene TherapyNanotechnology: Empowering Gene TherapyGene Therapy: A New Hope to Treat BlindnessGene Therapy: Potential Cure for Cancer

Winning Imperatives

Investment in R&D Activities

Key Topics Covered

1. Analyst View

2. Research Methodology

3. Gene Therapy - An Introduction

4. Industry Overview

5. Clinical Trial Assessment & Pipeline Analysis

6. Gene Therapy Market - Regulatory Landscape & Reimbursement Scenario

7. Marketed Gene Therapies

8. Gene Therapy Market

9. Gene Therapy Market by Application

10. Gene Therapy Market Size by Geography

11. Competitive Landscape

12. Key Players Analysis

Spark Therapeutics LLCViroMed Co. Ltd. dba VM BioPharmaAdvantagene Inc.Bluebird BioSanofiVical Inc.Oxford BioMedica PLCGenethonuniQure N.V.Human Stem Cells InstituteShanghai Sunway Biotech Co. Ltd.Sibiono GeneTech Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/62xvm7/global_and_us?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181108005676/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/08/2018 11:32 AM/DISC: 11/08/2018 11:31 AM

http://www.businesswire.com/news/home/20181108005676/en

AP RADIO
Update hourly